BMY vs RMBI · P/E 17, rev $24.46B vs P/E 16, rev $43.1M
Bristol-Myers Squibb Company (BMY) versus Richmond Mutual Bancorporation Inc (RMBI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Richmond Mutual Bancorporation Inc (RMBI) is a banks - regional company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported RMBI revenue for 2026-06-30 was $43.1M. Net income was $5.0M. RMBI currently screens at market cap $146.2M and trailing P/E 15.8.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. RMBI currently screens at market cap $146.2M and trailing P/E 15.8.
Not investment advice. Open the BMY and RMBI stock pages for the full models.
Not investment advice.